This study, published this week, confirms the general wisdom of this board -- doctors favor those PC treatments which they perform. The lesson: learn a lot -- get multiple opinions.
archinte.ama-assn.org/cgi/content/full/170/5/440?home"Overall, 42 309 men (50%) were seen exclusively by urologists, 37 540 (44%) by urologists and radiation oncologists, 2329 (3%) by urologists and medical oncologists, and 2910 (3%) by all 3 specialists. There was a strong association between the type of specialist seen and primary therapy received."
"Conclusions Specialist visits relate strongly to prostate cancer treatment choices. In light of these findings, prior evidence that specialists prefer the modality they themselves deliver and the lack of conclusive comparative studies demonstrating superiority of one modality over another, it is essential to ensure that men have access to balanced information before choosing a particular therapy for prostate cancer."
Arch Intern Med. 2010;170(5):440-450.